Group 1 - The core point of the announcement is the implementation of a sales service fee discount for the Huatai Zijin Daily Fund starting from November 24, 2025 [1][2] - The sales service fee rate during the promotional period will be set at 0.00% [2] - The specific details of the promotional activity may change, and the company will issue further announcements if necessary [3] Group 2 - The applicable fund for this promotional activity is the Huatai Zijin Daily Money Market Fund, with the fund code 940018 [1] - Investors are encouraged to read the fund contract, prospectus, and other legal documents for detailed information about the fund [3] - The announcement emphasizes that the company retains the right to interpret the announcement [3]

Group 1 - The fund, Huatai Zijin CSI Pharmaceutical 50 Index Fund, may trigger contract termination if its net asset value falls below 200 million yuan by April 29, 2025, which is three years after the contract's effective date [9] - The fund has been operating with a small scale, and if the asset size condition is not met, it will enter liquidation procedures starting April 30, 2025 [9][10] - Investors holding shares until the liquidation will be exempt from redemption fees [9] Group 2 - The fund will suspend subscription, regular investment, and conversion services starting April 8, 2025, and will also suspend redemption services from April 29, 2025, at 15:00 [10] - Investors are advised to complete any redemption requests before the specified deadline to avoid unprocessed applications [10] - The fund management will establish a liquidation team to handle the fund's assets according to relevant laws and regulations if the termination condition is triggered [10]